Tiny radiation dose may tame eye lymphoma
NCT ID NCT02494700
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study tests whether a very low dose of radiation (4 Gy) can control slow-growing B-cell lymphoma in the eye socket. About 50 adults with stage I-IV indolent lymphoma or mantle cell lymphoma will receive this targeted treatment. The goal is to shrink or stop the cancer while causing fewer side effects than standard radiation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANN ARBOR STAGE I B-CELL NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug cocktail aims to shrink lymphoma without chemo
- New Immunotherapy-Chemo cocktail takes on tough lymphoma
- Promising new combo aims to tame rare lymphoma with less radiation
- New drug duo aims to control lymphoma without chemo
- Immunotherapy-Chemo combo shows promise in aggressive lymphoma trial
- New cocktail of cancer drugs shows promise in early lymphoma trial